Motivating health workers for the provision of directly observed treatment to TB patients in rural china: Does cash incentive work? A qualitative study

International Journal of Health Planning and Management

Volumn 28, Issue 4, 2013, Pages

  Tao, Tao ^a   Zhao, Qi ^a   Jiang, Shiwen ^b   Ma, Liping ^c   Wan, Liya ^d,f   Ma, Yongcheng ^e   Xu, Biao ^a  

^a FUDAN UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c HENAN PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d Bureau of Disease Control   (China)

^e Qinghai Provincial Center for Disease Control and Prevention   (China)

^f Chinese Anti Tuberculosis Association   (China)

Author keywords

Directly observed treatment; Incentive; Rural health worker; Tuberculosis

Indexed keywords

HEALTH CARE; HEALTH SERVICES; HEALTH WORKER; INCENTIVE; TUBERCULOSIS;

CHINA;

EID: 84887083607     PISSN: 07496753     EISSN: 10991751     Source Type: Journal    
DOI: 10.1002/hpm.2175     Document Type: Article

References (38)

1. Beith A, Eichler R, Weil D. 2007. Performance-based incentives for health: a way to improve tuberculosis detection and treatment completion. Center for Global Development Working Paper No. 122. Available at SSRN: http://ssrn.com/abstract=1003247 or http://dx.doi.org/10.2139/ssrn.1003247.
2. Bhattacharyya K, Winch P, LeBan K, Tien M. 2001. Community Health Worker Incentives and Disincentives: How They Affect Motivation, Retention, and Sustainability. Basic Support for Institutionalizing Child Survival Project (BASICS II) for the United States Agency for International Development: Arlington, Virginia.
3. Chee CBE, Wang YT. 2012. TB control in Singapore: where do we go from here? Singapore Med J 53(4): 237.
4. Frieden TR, Driver CR. 2003. Tuberculosis control: past 10years and future progress. Tuberculosis (Edinb) 83(1-3): 82-85.
5. Frieden TR, Sbarbaro JA. 2007. Promoting adherence to treatment for tuberculosis: the importance of direct observation. Bull World Health Organ 85(5): 407-409.
6. Gai R, Xu L, Wang X, et al. 2008. The role of village doctors on tuberculosis control and the DOTS strategy in Shandong Province, China. Biosci Trends 2(5): 181.
7. Glenton C, Scheel IB, Pradhan S, Lewin S, Hodgins S, Shrestha V. 2010. The female community health volunteer programme in Nepal: decision makers' perceptions of volunteerism, payment and other incentives. Soc Sci Med 70(12): 1920-1927.
8. Hillman AL, Pauly MV, Kerman K, Martinek CR. 1991. HMO managers' views on financial incentives and quality. Health Aff (Millwood) 10(4): 207.
9. Hillman AL, Ripley K, Goldfarb N, Nuamah I, Weiner J, Lusk E. 1998. Physician financial incentives and feedback: failure to increase cancer screening in Medicaid managed care. Am J Public Health 88(11): 1699-1701.
10. Hoffman JA, Cunningham JR, Suleh AJ, et al. 2010. Mobile direct observation treatment for tuberculosis patients: a technical feasibility pilot using mobile phones in Nairobi, Kenya. Am J Prev Med 39(1): 78-80.
11. Hu D, Liu X, Chen J, et al. 2008. Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study. Health Policy Plan 23(1): 43.
12. Kangovi S, Mukherjee J, Bohmer R, Fitzmaurice G. 2009. A classification and meta-analysis of community-based directly observed therapy programs for tuberculosis treatment in developing countries. J Community Health 34(6): 506-513.
13. Kironde S, Bajunirwe F. 2003. Lay workers in directly observed treatment (DOT) programmes for tuberculosis in high burden settings: should they be paid? A review of behavioural perspectives. Afr Health Sci 2(2): 73-78.
14. Kironde S, Klaasen S. 2002. What motivates lay volunteers in high burden but resource-limited tuberculosis control programmes? Perceptions from the Northern Cape province, South Africa. Int J Tuberc Lung Dis 6(2): 104-110.
15. Meng Q, Li R, Cheng G, Blas E. 2004. Provision and financial burden of TB services in a financially decentralized system: a case study from Shandong, China. Int J Health Plann Manage 19(S1): S45-S62.
16. Minister of Health, China. 2005. Regulation of pulmonary tuberculosis case referral reward and management allowance. http://www.chinatb.org/zcfg/qgzcfg/201206/t20120601_61489.htm. (Accessed 10 August 2012).
17. Minister of Health, China. 2006. Sociological Assessment Report for Tuberculosis Control Projects in China. Peking Union Medical College Press: Beijing.
18. Minister of Health, China. 2008. Operational guidance for TB control and planning in China. http://www.moh.gov.cn/open/web_edit_file/20061127104545.doc. (Accessed 10 August 2012).
19. Mishra P, Hansen EH, Sabroe S, Kafle KK. 2006. Adherence is associated with the quality of professional-patient interaction in directly observed treatment short-course, DOTS. Patient Educ Couns 63(1): 29-37.
20. Mookherji S, Weil D, Beith A, Owunne C. 2005. Evaluating TB enablers and incentives workshop report: Paris, November 2003. Submitted to the US Agency for International Development by the Rational Pharmaceutical Management Plus Program. Arlington VA: Management Sciences for Health and Stop TB Partnership.
21. Ngamvithayapong J, Yanai H, Winkvist A, Saisorn S, Diwan V. 2001. Feasibility of home-based and health centre-based DOT: perspectives of TB care providers and clients in an HIV-endemic area of Thailand. Int J Tuberc Lung Dis 5(8): 741-745.
22. Noyes J, Popay J. 2007. Directly observed therapy and tuberculosis: how can a systematic review of qualitative research contribute to improving services? A qualitative meta-synthesis. J Adv Nurs 57(3): 227-243.
23. Patrick M, Teresa Q, Janice P, et al. 2011. Does directly observed therapy (DOT) reduce drug resistant tuberculosis? BMC Public Health 11: 19. DOI: 10.1186/1471-2458-11-19.
24. Rice PL, Ezzy D. 1999. Qualitative Research Methods: A Health Focus. Oxford University Press: Melbourne.
25. Rieder HL, Rusen ID, Trébucq A, et al. 2010. Management of Tuberculosis: A Guide to the Essentials of Good Practice. International Union Against Tuberculosis and Lung Disease: Paris, France.
26. Sun Q, Meng Q, Yip W, Yin X, Li H. 2008. DOT in rural China: experience from a case study in Shandong Province, China. Int J Tuberc Lung Dis 12(6): 625-630.
27. Twinn S. 1998. An analysis of the effectiveness of focus groups as a method of qualitative data collection with Chinese populations in nursing research. J Adv Nurs 28(3): 654-661.
28. Volmink J, Garner P. 2003. Directly observed treatment for tuberculosis less faith, more science would be helpful. BMJ 327(7419): 823-824.
29. Volmink J, Garner P. 2007. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev (4): CD003343. DOI: 10.1002/14651858.CD003343.pub3.
30. Wang Y. 2011. Summary of 5th National TB Epidemiological Sample Survey. Military Medical Science Press: Beijing.
31. Wang L, Liu J, Chin DP. 2007. Progress in tuberculosis control and the evolving public-health system in China. Lancet 369(9562): 691-696.
32. Wei X, Walley J, Zhao J, Yao H, Liu J, Newell J. 2009. Why financial incentives did not reach the poor tuberculosis patients? A qualitative study of a Fidelis funded project in Shanxi, China. Health Policy 90(2-3): 206-213.
33. Weis SE, Slocum PC, Blais FX, et al. 1994. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 330(17): 1179-1184.
34. WHO. 2011. Global tuberculosis control 2011. WHO Report WHO/HTM/TB/2011.16.
35. Xu B, Fochsen G, Xiu Y, Thorson A, Kemp JR, Jiang QW. 2004. Perceptions and experiences of health care seeking and access to TB care-a qualitative study in Rural Jiangsu Province, China. Health Policy 69(2): 139-149.
36. Yao H, Wei X, Liu J, Zhao J, Hu D, Walley JD. 2008. Evaluating the effects of providing financial incentives to tuberculosis patients and health providers in China. Int J Tuberc Lung Dis 12(10): 1166-1172.
37. Zhao Y, Xu S, Wang L, et al. 2012. National survey of drug-resistant tuberculosis in China. N Engl J Med 366(23): 2161-2170.
38. Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M. 1998. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 352(9137): 1340-1343.